title: Evaluation of interleukin-17 serum levels in patients with chronic myeloproliferative diseases.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Allegra
authors.forename: Andrea
authors.initials: A
authors.lastname: Alonci
authors.forename: Giacomo
authors.initials: G
authors.lastname: Bellomo
authors.forename: Arianna
authors.initials: A
authors.lastname: D'Angelo
authors.forename: Angela
authors.initials: A
authors.lastname: Granata
authors.forename: Sabina
authors.initials: S
authors.lastname: Russo
authors.forename: Eugenia
authors.initials: E
authors.lastname: Quartarone
authors.forename: Caterina
authors.initials: C
authors.lastname: Musolino
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D020381:Interleukin-17 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000097:blood*; D011237:Predictive Value of Tests; D055728:Primary Myelofibrosis / Q000097:blood
chemical_list: D014408:Biomarkers, Tumor; D020381:Interleukin-17